IPA (ImmunoPrecise Antibodies)

📍 Fargo, United States🗓 Founded 1989👥 77 employees💰 Last funded Aug 2023
Biotechnology Research🌐 ipatherapeutics.com
Website LinkedIn
IPA is a progressive, scientific Contract Research Organization (CRO) recently ranked by one of the pharmaceutical industry’s most trusted, independent market research sources with the highest competitive score, for its antibody service portfolio.1 The company represents a HUB of biotherapeutic intelligence that includes a hybrid of experts and technologies, in the science and business of bioplatform-based discovery. We provide highly specialized full-continuum therapeutic antibody discovery, development, and out-licensing services [Talem] —with advanced omics and complex intelligence technology [LENSai] that provide greater efficiency and accuracy than ever before. Our mission is to provide our pharmaceutical customers with a HUB of the most advanced intelligence and technology to treat disease, bar none. Our goal — is to improve the specificity of biotherapeutics by unlocking the language of the genome. 1. ROOTS 2022: Antibody Discovery Services and Platforms Market (Industry Trends and Global Forecast, 4th Edition), 2021-2035​; p.118
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
1989
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Belgium
1
United States
1
Canada
1
Investor activity2016–2023 · investors recorded per year
201612021120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in IPA (ImmunoPrecise Antibodies)?
IPA (ImmunoPrecise Antibodies) has 3 investors on record on gritt.io.
When did IPA (ImmunoPrecise Antibodies) last raise funding?
The most recent investment in IPA (ImmunoPrecise Antibodies) recorded on gritt.io was in August 2023.
When was IPA (ImmunoPrecise Antibodies) founded?
IPA (ImmunoPrecise Antibodies) was founded in 1989.
What industry is IPA (ImmunoPrecise Antibodies) in?
IPA (ImmunoPrecise Antibodies) operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IPA (ImmunoPrecise Antibodies) based?
IPA (ImmunoPrecise Antibodies) is headquartered in Fargo, United States.